Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer

Clinical trial NCT05982093 · RECRUITING

Trial details

NCT number: NCT05982093
Sponsor: SOLTI Breast Cancer Research Group
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer HER2-negative Breast Cancer Hormone Receptor Positive Tumor Premenopausal Breast Cancer

Start date: 2023-02-03
Primary completion: 2026-12-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.